Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
Urinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in si...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/422 |
id |
doaj-0dda59f830d840f6aebd71e90b828fe9 |
---|---|
record_format |
Article |
spelling |
doaj-0dda59f830d840f6aebd71e90b828fe92021-01-24T00:01:16ZengMDPI AGCancers2072-66942021-01-011342242210.3390/cancers13030422Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s TreasureSarah Minkler0Fabrice Lucien1Michael J. Kimber2Dipak K. Sahoo3Agnes Bourgois-Mochel4Margaret Musser5Chad Johannes6Igor Frank7John Cheville8Karin Allenspach9Jonathan P. Mochel10SMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Urology, Mayo Clinic, Rochester, MN 55902, USADepartment of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USASMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Urology, Mayo Clinic, Rochester, MN 55902, USADepartment of Urology, Mayo Clinic, Rochester, MN 55902, USASMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USASMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USAUrinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in significant health care costs. The development of innovative molecular and cellular tools is necessary to refine patient stratification and help predict response to treatment. Urine is an underused resource of biological components shed from bladder tumors, such as exfoliated cells and extracellular vesicles, that could serve as molecular fingerprints and provide valuable biological insights into tumor phenotype and mechanisms of resistance to chemotherapy. Additionally, characterization of urine-derived extracellular vesicles and cells could be used as reliable biomarkers for prediction of response to neoadjuvant therapy.https://www.mdpi.com/2072-6694/13/3/422bladder cancerorganoidsexosomesprecision medicineone health |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sarah Minkler Fabrice Lucien Michael J. Kimber Dipak K. Sahoo Agnes Bourgois-Mochel Margaret Musser Chad Johannes Igor Frank John Cheville Karin Allenspach Jonathan P. Mochel |
spellingShingle |
Sarah Minkler Fabrice Lucien Michael J. Kimber Dipak K. Sahoo Agnes Bourgois-Mochel Margaret Musser Chad Johannes Igor Frank John Cheville Karin Allenspach Jonathan P. Mochel Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure Cancers bladder cancer organoids exosomes precision medicine one health |
author_facet |
Sarah Minkler Fabrice Lucien Michael J. Kimber Dipak K. Sahoo Agnes Bourgois-Mochel Margaret Musser Chad Johannes Igor Frank John Cheville Karin Allenspach Jonathan P. Mochel |
author_sort |
Sarah Minkler |
title |
Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure |
title_short |
Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure |
title_full |
Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure |
title_fullStr |
Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure |
title_full_unstemmed |
Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure |
title_sort |
emerging roles of urine-derived components for the management of bladder cancer: one man’s trash is another man’s treasure |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2021-01-01 |
description |
Urinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in significant health care costs. The development of innovative molecular and cellular tools is necessary to refine patient stratification and help predict response to treatment. Urine is an underused resource of biological components shed from bladder tumors, such as exfoliated cells and extracellular vesicles, that could serve as molecular fingerprints and provide valuable biological insights into tumor phenotype and mechanisms of resistance to chemotherapy. Additionally, characterization of urine-derived extracellular vesicles and cells could be used as reliable biomarkers for prediction of response to neoadjuvant therapy. |
topic |
bladder cancer organoids exosomes precision medicine one health |
url |
https://www.mdpi.com/2072-6694/13/3/422 |
work_keys_str_mv |
AT sarahminkler emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT fabricelucien emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT michaeljkimber emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT dipakksahoo emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT agnesbourgoismochel emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT margaretmusser emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT chadjohannes emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT igorfrank emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT johncheville emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT karinallenspach emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure AT jonathanpmochel emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure |
_version_ |
1724326939086290944 |